International ID
News
FDA approves rifamycin for treatment of traveler’s diarrhea
Rifamycin wins FDA approval for management of E. coli-related traveler's diarrhea.
News from the FDA/CDC
FDA authorizes emergency use of rapid fingerstick test for Ebola
The DPP Ebola Antigen System can provide rapid results in locations where health care providers lack access to authorized Ebola virus nucleic acid...
Conference Coverage
Cholera, bacteriophage in an epic evolutionary struggle
SAN FRANCISCO –
From the Journals
Arginine deficiency implicated in novel hemorrhagic fever fatality
Conference Coverage
UN aims to eradicate TB by 2030
A concerted a lethal disease affecting one-...
Conference Coverage
Cutaneous lesions? Consider C. diphtheriae in those with foreign travel
ATLANTA –
News
CDC supports Ebola response in DRC
The
News
FDA: Krintafel approved as ‘radical cure’ for preventing malaria relapse
The FDA has approved single-dose tafenoquine (to be marketed as Krintafel) for the prevention of relapse in patients receiving appropriate...
News
Female survivor transmits Ebola virus 1 year after outbreak
...
From the Journals
Mosaic HIV-1 vaccine stimulates broad antigenicity, enters phase 2b human efficacy trial
From the Journals
Primary efficacy not met by new M. tuberculosis vaccine strategies
“These encouraging findings provide an impetus to reevaluate the use of BCG revaccination of populations that are free of M. tuberculosis...